Hepatitis B, hepatitis C, and HIV in correctional populations: A review of epidemiology and prevention

AIDS

Volumn 19, Issue SUPPL. 3, 2005, Pages

  Weinbaum, Cindy M ^a   Sabin, Keith M ^a   Santibanez, Scott S ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Epidemiology; Hepatitis B; Hepatitis B vaccination; Hepatitis C; HIV; Inmates; Prevention; Prison; Review

Indexed keywords

BODY BURDEN; COMORBIDITY; DRUG USE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MEDICAL CARE; MEDICAL DOCUMENTATION; MORBIDITY; MORTALITY; NONHUMAN; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; PRISON; REVIEW; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; UNITED STATES; VACCINATION; VIRUS TRANSMISSION;

EID: 27944448408     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000192069.95819.aa     Document Type: Review

References (50)

1. National Commission on Correctional Health Care. The health status of soon-to-be-released inmates. A report to Congress. National Commission on Correctional Health Care 1: Chicago, IL; 2002.
2. Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR 2003; 52(RR-1):1-36.
3. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health 2002; 92:1789-1794.
4. Harrison P, Beck AJ. Prisoners in 2002. Bureau of Justice Statistics, editor. NCJ 195189. Washington, DC: US Department of Justice, Office of Justice Programs; 2003.
5. Greenfield T, Snell T. Women offenders. BJS special report. NCJ 175866, Washington, DC: Bureau of Justice Statistics; 1999. pp. 1-14.
6. Harrison P, Karberg JC. Prison and jail inmates at midyear 2001. Bureau of Justice Statistics, editor. NCJ198877. Washington, DC: US Department of Justice, Office of Justice Programs; 2003.
7. Glaze L. Probation and parole in the United States, 2002. Bureau of Justice Statistics, US Department of Justice, editors. NCJ 201135. Washington, DC: US Department of Justice; 2003.
8. Goldstein ST, Alter MJ, Williams IT, Moyer LA, Judson FN, Mottram K, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 2002; 185:713-719.
9. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2002. Vol. 14. Atlanta, GA: CDC; 2003.
10. Murray KF, Richardson LP, Morishima C, Owens JW, Gretch DR. Prevalence of hepatitis C virus infection and risk factors in an incarcerated juvenile population: a pilot study. Pediatrics 2003; 111:153-157.
11. Mumola C. Substance abuse and treatment, state and federal prisoners, 1997. US Department of Justice, editor. NCJ 172871. Office of Justice Programs. Bureau of Justice Statistics, Special Report: Washington, DC; 1999.
12. Wilson DJ. Drug use, testing, and treatment in jails. US Department of Justice, editor. NCJ 179999. Office of Justice Programs. Bureau of Justice Statistics, Special Report: Washington, DC; 2000. pp. 1-12.
13. US Department of Justice, Office of Justice Programs. 2000 Arrestee drug abuse monitoring. Annual Report. NCJ 193013. Washington, DC: US Department of Justice; 2003.
14. Office of Applied Statistics S, RTI. The NHSDA report: injection drug use. 3-14-003. NHSDA Report. US Department of Health and Human Services. Washington, DC; 14 March 2003.
15. Wolfe MI, Xu F, Patel P, O'Cain M, Schillinger JA, St Louis ME, et al. An outbreak of syphilis in Alabama prisons: correctional health policy and communicable disease control. Am J Public Health 2001; 91:1220-1225.
16. MacGowan RJ, Margolis A, Gaiter J, Morrow K, Zack B, Askew J, et al. Predictors of risky sex of young men after release from prison. Int J STD AIDS 2003; 14:519-523.
17. Seal DW, Margolis AD, Sosman J, Kacanek D, Binson D. HIV and STD risk behavior among 18- to 25-year-old men released from U.S. prisons: provider perspectives. AIDS Behav 2003; 7:131-141.
18. Mertz KJ, Voigt RA, Hutchins K, Levine WC. Findings from STD screening of adolescents and adults entering corrections facilities: implications for STD control strategies. Sex Transm Dis 2002; 29:834-839.
19. Blank S, Sternberg M, Neylans LL, Rubin SR, Weisfuse IB, St Louis ME. Incident syphilis among women with multiple admissions to jail in New York City. J Infect Dis 1999; 180:1159-1163.
20. Centers for Disease Control and Prevention. Assessment of sexually transmitted disease services in city and county jails - United States, 1997. MMWR 1998; 47:429-431.
21. Wolitski RJ, for the Project START Study Group. Project START reduces HIV risk among prisoners after release. In: XVth International Conference on AIDS. Bangkok, Thailand, 11 July 2004 [Abstract WeOrC1296].
22. Margolis AD, Wolitski RJ, Seal DW, Belcher L, Morrow K, Sosman JM, et al. Sexual behavior and substance use during incarceration. In: XVth International Conference on AIDS. Bangkok, Thailand, 11 July 2004 [Abstract ThPeC7474].
23. Wohl AR, Johnson D, Jordan W, Lu S, Beall G, Currier J, Kerndt P. High-risk behaviors in and out of incarcerated settings for African American men treated for HIV at three Los Angeles public medical centers [Abstract no. 485]. In: 7th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA; 30 January 2000.
24. Lane SD, Rubinstein RA, Keefe RH, Webster N, Cibula DA, Rosenthal A, et al. Structural violence and racial disparity in HIV transmission. J Health Care Poor Underserved 2004; 15:319-335.
25. Coleman PJ, McQuillan GM, Moyer LA, Lambert SB, Margolis HS. Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis 1998; 178:954-959.
26. McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999; 89:14-18.
27. Macalino G, Salas CM, Towe CW, Foisie CK, McKenzie M, Spaulding A, Rich J. Incidence and community prevalence of HIV and other blood borne pathogens among incarcerated women in Rhode Island [Abstract no. 610]. Presented at the National HIV Prevention Conference. Atlanta, GA: US Department of Health and Human Services, CDC; 1999.
28. Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island Prisons. Am J Public Health 2004; 94:1218-1223.
29. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40(RR-13):1-25.
30. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-562.
31. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47(RR-19):1-39.
32. Vlahov D, Nelson KE, Quinn TC, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 1993; 9:566-569.
33. Fleming P, Byers RH, Sweeney PA, Daniels D, Karon JM, Janssen RS. HIV prevalence in the United States, 2000. In: Program and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, 24-28 February 2002 (Alexandria, Virginia: Foundation for Retrovirology and Human Health).
34. Vu MQ, Steketee RW, Valleroy L, Weinstock H, Karon J, Janssen R. HIV incidence in the United States, 1978-1999 [Abstract no. 11]. J Acquir Immune Defic Syndr 2002; 31:188-201.
35. US Department of Justice, Bureau of Justice Statistics. HIV in prisons, 2001. NCJ 202293. Bureau of Justice Statistics Bulletin: Washington, DC; 2004.
36. Dean-Gaitor HD, Fleming PL. Epidemiology of AIDS in incarcerated persons in the United States, 1994-1996. AIDS 1999; 13:2429-2435.
37. Bureau of Justice Statistics, US Department of Justice. HIV in prisons and jails, 1999. NCJ 187456. Office of Justice Programs: Washington, DC; 2001.
38. Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health 2004; 81:25-37.
39. Weinbaum CM, Sabin K, Soofi H, Griffin V, Kim A. Coinfections with HIV, HBV, and HCV in arrestees: results from a three-jail study [Abstract no. 5097.0]. In: 131st Annual Meeting of the American Public Health Association. San Francisco, CA, 15-19 November 2003.
40. Centers for Disease Control. Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine. MMWR 1982; 31:317-318.
41. Centers for Disease Control. Perspectives in disease prevention and health promotion public health service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR 1987; 36:509-515.
42. Belenko S. Behind bars: substance abuse and America's prison population. New York: National Center on Addiction and Substance Abuse at Columbia University; 1998.
43. Grinstead OA, Zack B, Faigeles B. Collaborative research to prevent HIV among male prison inmates and their female partners. Health Educ Behav 1999; 26:225-238.
44. Khan A, Goldstein ST, Williams IA, Bell BP, Mast EE. Opportunities for hepatitis B prevention in correctional facilities and sexually transmitted disease treatment settings. Antiviral Ther 2000; 5 (Suppl. 1):22.
45. Beck A, Maruschak LM. Hepatitis testing and treatment in state prisons. Bureau of Justice Statistics, editor. NCJ199173. Washington, DC: US Department of Justice, Office of Justice Programs; 2004.
46. Centers for Disease Control and Prevention. Hepatitis B vaccination of inmates in correctional facilities - Texas, 2000-2002. MMWR 2004; 53:681-683.
47. Weinbaum C, Goldstein S, Subiadur J. Hepatitis B in women: domestically and internationally [Conference summary]. Emerg Infect Dis (serial on the Internet); November 2004 [accessed 1 June 2005]. Available at: http://www.cdc.gov/ncidod/EID/voll0noll/04-062402.htm.
48. National Institutes of Health. Consensus development conference statement: management of hepatitis C: 10-12 June 2002. Hepatology 2002; 36 (5 Suppl. 1):S3-S20.
49. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic - United States, 2003. MMWR 2003; 52:329-332.
50. Arriola KR, Braithwaite RL, Kennedy S, Hammett T, Tinsley M, Wood P, et al. A collaborative effort to enhance HIV/STI screening in five county jails. Public Health Rep 2001; 116:520-529.